A review on HCV inhibitors: Significance of non-structural polyproteins

NM Ganta, G Gedda, B Rathnakar… - European journal of …, 2019 - Elsevier
Hepatitis C virus (HCV) mortality and morbidity is a world health misery with an approximate
130–150 million chronically HCV tainted and suffering individuals and it initiate critical liver …

Comparison of Compliance and Efficacy of Pegylated Interferon α-2a and α-2b in Adults with Chronic Hepatitis C

JH Hu, ML Chang, TJ Huang, CT Yeh… - Journal of Interferon & …, 2019 - liebertpub.com
This study compares treatment completion rates and outcomes in hepatitis C virus (HCV)
patients between those aged< 60 and≥ 60 years receiving pegylated interferon (PEG-IFN) …

[引用][C] 干扰素α-2a 与α-2b 的免疫原性研究

李运龙, 邱峰, 赵青青, 龙锐, 张莎, 黄丹 - 重庆医科大学学报, 2019